Severe hypothyroidism is associated with a high burden of systolic/diastolic ventricular dysfunction and myocardial deformation abnormalities.

Aisa Pharma announces positive results from phase 2 RECONNOITER trial of cilnidipine in patients with systemic sclerosis-associated Raynaud's phenomenon: Boston Monday, March 9, 2 ...

TD Cowen 46th Annual Health Care Conference March 4, 2026 10:30 AM ESTCompany ParticipantsBrian Sullivan - Co-Founder, Chairman ...

The UConn School of Dental Medicine celebrates a big milestone for second-year students during the annual White Coat ...

Prendiville has built a curated model of care for senior citizens that champions a listening-first approach, embedded to ...

The exported NPX-5 product will now be used in Psyence BioMed’s ongoing Phase IIb clinical trial in Australia – a double-blind, randomized, low-dose comparator-controlled, multi-center study ...

Examining brain plasticity and its implications for development, aging, and brain injury recovery.

FDA's Plausible Mechanism Framework streamlines individualized therapy approvals for ultra-rare diseases.

Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...

FOSHAN, GUANGDONG, CHINA, February 27, 2026 /EINPresswire.com/ -- As the global beauty landscape undergoes a profound ...

When outcome selection and prioritisation are defined early in development, the evidence base supports continuity from trial ...

In exploring barriers in rare disease research and drug development, experts highlight a lack of robust models, limited trial ...